mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.005 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.009 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |